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Abstract
The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of
reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh
reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in
non-endemic countries. Here, we describe a new method for the cryopreservation of HSC-derived reticulocytes to be used
for both P. falciparum and P. vivax invasion tests. Cryopreserved P. falciparum and P. vivax isolates could invade both fresh
and cryopreserved HSC-derived reticulocytes with similar efficiency. This new technique allows the storage of HSC-derived
reticulocytes which can be used for later invasion tests and represents an important step towards the establishment of
a continuous P. vivax culture.
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Introduction
Outside sub-Saharan Africa, Plasmodium vivax is the most
common human plasmodium species [1]. Though it has long
been considered as less dangerous than P. falciparum, severe and
fatal P. vivax cases as well as drug resistant parasites are now
increasingly reported [2,3,4,5]. Understanding of the biology and
the transmission dynamics of P. vivax lags behind that of
P. falciparum, partly because the maintenance of a continuous line
of this parasite in vitro has not been established. The availability of
an in vitro culture system would improved our understanding of the
biology of P. vivax, e.g. invasion and relapse mechanisms,
resistance markers, and would contribute to the development of
new treatments and vaccines.
P. vivax preferentially invades reticulocytes [6] and thus in order
to achieve a continuous in vitro culture system the availability of
large amounts of these young red blood cells, which circulate in
the peripheral blood at low concentration (1% of total red blood
cells) and for a very short time (24 h), is required. Russell et al. [7]
recently published a reliable invasion assay protocol using fresh
P. vivax schizonts from fresh clinical isolates and enriched cord
blood reticulocytes. It has been previously shown that reticulocytes
can also be successfully produced through the differentiation of
hematopoietic stem cells (HSC) [8] and that such HSC-derived
reticulocytes may be used for P. vivax culture, though both the
reticulocyte production and the parasite densities obtained were
extremely low [9]. The contribution of this paper is to report an
improved method to produce and cryopreserve HSC-derived
reticulocytes to be later invaded by P. vivax, allowing research on
P. vivax culture to be carried out outside endemic areas, increasing
the number of teams potentially working on this subject and hence
the chances for major discoveries.
Materials and Methods
Ethics Statement
P. vivax sample collection: MUTM 2008-15 from the
ethics Committee of the faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand.
Cord blood sample collection: blood was collected
anonymously and patients were informed orally with a possibility
of opting-out. Each Patient was notified on the hospital admission
form of this opting-out possibility.
Procedure was accepted by ethic committee of UZA and ITM.
Study was approved by the ITM review board, number:
SBB.219.2007/1410.
Hematopoietic Stem Cell (HSC) Isolation
Umbilical cord blood samples (40 ml each) were collected from
pregnant women delivering at the University hospital, Antwerp
(UZA), after obtaining an individual informed consent. Mono-
nuclear cells (MNC) were separated by Ficoll-Isopaque (GE
Healthcare) centrifugation (250 g, 10 min) and enriched for
CD34+ cells by supermagnetic microbead selection using Mini-
MACS columns (Miltenyi Biotech) according to a previously
published procedure [10].
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HSC Culture
The amplification procedure was adapted from a three-step
expansion of CD34+ cells by sequential supply of the culture with
specific combination of cytokines and growth factors [11]. HSCs
isolated from cord blood were cultured at 37uC, 5% CO2 in
a modified serum-free media (IMDM, Biochrom) supplemented
with L- Glutamine (4 mM, Sigma), Penicilline/Streptomycine
(1%, Invitrogen), Inositol (40 mg/ml, Sigma), Folic acid (10 mg/
ml, Sigma), Monothioglycerol (1.6 1024 M, Sigma), Transferrin
(120 mg/ml, Sigma), insulin (10 mg/ml, Sigma), Bovine Serum
Albumin detoxified by beads resin AG501-X8 (Biorad) (BSA,
100 mg/ml, PAA) [12].
Step 1 (day 0 to 8): CD34+ cells were cultured with Stem Cell
Factor (SCF, 100 ng/ml, Bioke), IL-3 (5 ng/ml, R&D System),
Hydrocortisone (HDS, 1026 M, Sigma), and Erythropoietin
(EPO, 3 IU/ml, R&D System). At day 4, cells were diluted 1:2
in IMDM medium completed with all the four above mentioned
growth factors and incubated at 37uC for 4 additional days. At day
7, cells were re-suspended (106 cells per vial) in culture medium
(IMDM) and an equal volume of 80% Foetal Calf Serum (FCS)/
20% DMSO solution was added drop by drop to obtain an
IMDM/40% FCS/10% DMSO solution before progressively
freezing them at 280uC using a Mr Frosty [13].
Step 2 (day 8–11): at day 8, 250 000 cells were added to each
25 cm2 flask and incubated in 5 ml of IMDM medium
supplemented with only EPO (3 IU/mL).
Step 3 (day 11–20): the culture was maintained in IMDM
without growth factors or cytokines and the medium was changed
every 3 days. The culture was stopped at day 14 corresponding to
the peak of reticulocytes counts determined by microscopic
examination of thin films done by cytospin (Thermo scientific):
200 000 cells were washed with PBS once and re-suspended in
50 mL of PBS. 50 mL of Cresyl Blue(Merck)(previously diluted 1/
100) were added to the tube and incubated 30 minutes. FCS
(30 mL) was added to protect cells during cytospin centrifugation
and the cells were placed in a cytospin funnel. After a centrifuga-
tion (700 rpm, 3 minutes), slides were removed from the funnel
and stained with Giemsa. A reticulocyte scoring positive would
contain two or more blue-stained RNA granules.
HSC Cryopreservation
HSC derived reticulocytes at day 14 in the culture were
subjected to three different cryopreservation protocols:
Glycerolyte solution [14]: 100 mL of Glycerolyte (Baxter)
were drawn up to the cell pellet using an insulin syringe. Firstly,
20% of the volume of Glycerolyte was added to the blood cell
suspension drop by drop while continuously agitating the tube to
mix the content. This suspension was incubated 5 minutes at room
temperature before adding the rest of Glycerolyte. RBC-Glycer-
olyte mixture was then aliquoted into cryovials and frozen at
280uC overnight before being stored in liquid nitrogen.
Glycerol & Sorbitol solution [15]: Cells were frozen in
a medium composed of 28% glycerol, 3% sorbitol, and 0,9% NaCl
diluted in distillate water. This solution was added drop by drop to
packed cells, at room temperature. Cells were immediately
transferred at 280uC.
IMDM/10% DMSO/40% FCS solution [16]: Cells were
frozen according to a standard method with medium containing
10% DMSO/40% FCS as described above for the HSC culture at
day 7.
Reticulocytes were kept in liquid nitrogen up to 1 year. Cells
were thawed following the same protocol as for Plasmodium
falciparum: the volume (V) of the thawed content was measured
and transferred to a 50 ml centrifuge tube. Then 0.1 V of pre-
warmed (37uC) 12% NaCl solution was added drop by drop to the
parasitized red blood cells (pRBC), which were allowed to stay for
5 min at room temperature. Subsequently 10 V of 1.6% NaCl
solution (pre-warmed at 37uC) were carefully added to the cells,
which were then centrifuged for 10 min at 650 g without applying
a break. The supernatant was discarded and 10 ml of 0.9% NaCl
solution pre-warmed at 37uC was carefully added to the pellet,
followed by a 5 min centrifugation at 650 g [17]. The cryopres-
ervation protocols were evaluated according to the following
criteria: viability of the cells after thawing, preservation of the
reticulocyte population, presence or absence of clots, and presence
of invaded reticulocytes by Plasmodium.
FACS Analysis
HSCs cultures were analysed by flow cytometer at day 8, 11, 14
and 17 of their in-vitro maturation. After thawing the cryopre-
served reticulocytes they were analysed by FACS, to assess the
expression of stage specific markers: CD36, CD45, CD71 and
CD235a. Briefly, 200 000 cells were centrifuged for 5 min at
650 g. The pellet was re-suspended in 100 mL of PBS buffer. 5 ml
of CD45-PE (BD bioscience), 10 mL of CD71-APC (BD bio-
science), 5 mL of CD36-FITC (BD bioscience), and 5 mL of
CD235-PerCP (BD bioscience), were added to the cells and
incubated for 15 min at room temperature in the dark. One tube
containing only antibody isotypes coupled to fluorochromes was
used as a negative control: 10 mL of IgG1c-PE (BD bioscience),
5 mL of IgM-FITC (BD bioscience), 5 mL of IgG1 K isotype-
PerCP (BD bioscience), and 5 mL of IgG1 K isotype-APC (BD
bioscience). After incubation cells were washed with FACS buffer
(Miltenyi Biotech) and re-suspended in 500 mL of buffer before
analysis. FACS analysis were carried out on a FACScalibur 4 color
cytometer (BD bioscience).
Hemoglobin Content
The haemoglobin (Hb) content (foetal or adult haemoglobin) of
the HSC derived reticulocytes was analyzed using the Kleihauer
method [18]. Umbilical cord blood ($95% of foetal Hb) and adult
peripheral blood ($95% of adult Hb ) were used as controls. Cells
containing foetal haemoglobin will be stained in red whereas cells
containing adult haemoglobin will look empty and only their
membranes will be observed.
Plasmodium Falciparum
P. falciparum D10 strains, cultured and cryopreserved in the
Institute of Tropical Medicine, Antwerp, Belgium, (ITMA)
cryobank were used for this study. Parasite isolates were thawed
in a 37uC incubator until no ice was left in the tube. The thawing
protocol was the same as the one used for reticulocytes. To check
for the invasion of new RBCs (RBC derived from HSC
maturation) by P. falciparum, pRBC were concentrated on
a Percoll gradient (90%, 70%, and 40%; Sigma) [19] and
centrifuged for 30 min at 2600 g without applying a break. After
centrifugation, the layer between the 70% and 40% Percoll was
kept, transferred into a new tube and washed with RPMI (Lonza).
1 ml of purified pRBC ($90% mature forms) was mixed with 4 mL
of the HSCs derived reticulocytes and 94 mL of RPMI medium
supplemented with HEPES (25 mM, Lonza), L-glutamine
(1 mM), gentamycin (40 mg/ml, Sigma), D-glucose (2%, Sigma),
hypoxanthine (50 mg/L, Sigma) diluted in NaOH 1 M and 10%
heat inactivated Human Serum (final volume: 100 mL, haemato-
crit 5%). The culture was incubated in a hermetic chamber flushed
gas (90% N2, 5% CO2, 5% O2) at 37uC for 24 h. Parasite
invasion was determined by microscopic examination of Giemsa
stained thin films. The number of newly invaded cells by
Frozen Reticulocytes for P. vivax Invasion
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P. falciparum ring stages were counted and divided by the total
number of cells to obtain the parasite density (% of invaded RBC).
For each experiment, two technicians independently examined the
slides and the mean parasite density was taken as the final value. If
reading results were discordant (parasite counting difference
$30%), both technicians re-read the slide until an agreement
was found.
Plasmodium Vivax
P. vivax isolates were collected from patients with acute P. vivax
malaria (mono-infection with a density of .1 parasite/1000 red
blood cells) attending the clinics of the Shoklo Malaria Research
Unit (SMRU, Mae Sot, North-West Thailand), after obtaining
their individual written informed consent. P. vivax isolates
contained more than 80% early ring forms. White blood cells
were removed after filtration on CF11 column (Whatmann) [20];
Parasites were frozen in Glycerolyte solution [21], as described
above, and then transferred and kept in liquid nitrogen at the
ITMA. Subsequently, P. vivax isolates were thawed following the
same protocol as described above for P. falciparum, and were re-
suspended in pre-warmed 37uC McCoy’s 5A (Gibco) medium
supplemented with 20% heat inactivated human serum from
normal AB group donors and 0.5% D-glucose. The medium
containing P. vivax was then transferred to a 25 cm2 culture flask,
flushed with gas (90% N2, 5% CO2, 5% O2), and placed in a 37uC
incubator for 36 to 44 hours to allow the maturation into
schizonts. Parasite stage was determined by microscopic exami-
nation of Giemsa stained thick and thin films. Mature schizonts
were concentrated in 45% Percoll by centrifugation for 15 minutes
at 1580 g without applying a break (Sigma) [22]. Purified schizonts
($90% mature forms) were mixed with HSCs derived reticulo-
cytes resulting in a starting parasite density between 0.5 and 1%.
Complete Mc Coy’s medium was added in order to obtain a 5%
haematocrit level and the culture was incubated at 37uC in
a hermetic chamber flushed for 24 h with gas (90% N2, 5% CO2,
5% O2) [7]. The efficiency of invasion was checked as described
above for P. falciparum.
Data Analysis
During HSC maturation, reticulocytes and RBC were counted
for each selected day during the maturation process. Median value
and interquartile range (IQR) were calculated for the reticulocytes
counts (6 independent experiments) as well as for the expression of
the surface markers measured by FACS (3 independent experi-
ments). Parasite densities for P. vivax invasion assays were
calculated per 500 counted cells. The number of infected cells
was divided by the total number of counted cells and multiplied by
100 to obtain a percentage.
Results
Amplification of Erythroid Cells
Microscopic examination of thin films of the erythroid cells
(Figure 1) confirmed a normal differentiation pattern and the
commitment of the HSC culture to the erythroid lineage as
defined elsewhere [23]. A total of 30 independent experiments
were successfully carried out, and median reticulocyte and RBC
population counts were computed at regular intervals (every 3 days
between day 8 and day 20) for 6 experiments (Figure 2). The first
reticulocytes were observed at day 12 of differentiation, and their
number dramatically increased between days 13 and 14 (from 5%
to 18%), corresponding to a peak of enucleation. Subsequently,
the percentage of reticulocytes decreased steadily (10% at day 16)
and almost disappeared at day 19 of differentiation. The
haemoglobin content measured at day 14 of maturation was
mainly foetal (about 90%, data not shown). Mature red blood cells
(RBC) showed an opposite trend as compared to reticulocytes as
they started to increase following the reticulocyte peak (0.4% at
day 15), outnumbered the reticulocytes at day 17 and reached
a plateau of above 20% at day 20. After cryopreservation, the cells
viability was up to 70% and the proportion of reticulocytes
remained stable compared to the one before freezing (except for
glycerolyte which was not tested due to the presence of clots during
the thawing process).
FACS Analysis of HSC Maturation
The proportion of positive cells expressing different surface
markers was calculated at different time points (Figure 3a). The
CD45, a specific marker for young cells (pre-proerythroblast
stage), decreased dramatically from 90% at day 8 to 3% at day 11,
while CD235a (Glycophorin A marker) followed the opposite
trend. Both CD71 and CD36 (both markers of stages between the
Figure 1. Production of reticulocytes from HSCs, morphologic analysis after Giemsa staining. (A) Human CD34+ cells isolated from cord
blood (B) Day 4 of culture, (C) Day 8- (D) Day 11- (E) Day 14 of culture, reticulocytes are highlighted by cresyl blue staining (arrows).
doi:10.1371/journal.pone.0040798.g001
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proerytroblast and mature RBC) were highly expressed at day 8,
100% and 80% respectively, and decreased following a different
pattern until day 17: the CD71 decreased slightly to 65% at day
17, while the CD36 dramatically decreased to less than 10% at
day 17. A freezing cycle (up to 1 year in the frame of this work) of
the HSC derived reticulocytes which were matured till day 14 did
not affect the expression of specific reticulocytes markers for any of
the three protocols tested. Indeed the comparison with the freshly
produced HSC derived reticulocytes gave similar results:
(Figure 3b) a high expression of CD71 (between 95% and 98%
according to the freezing protocol versus 90% for fresh reticulocytes
at day 14), and CD235a (between 90 and 98% versus 90% in fresh
reticulocytes), a quasi-absence of CD45 (around 0.5% versus 1%),
and the expression of CD36 reaching 30% for the 3 protocols
tested (versus 40%).
Invasion Assays
Both P. falciparum and P. vivax could successfully invade freshly
HSC derived reticulocytes (Figure 4a and 4b). Parasite density
after invasion of fresh reticulocytes was around 0.5% for P. vivax
and 4% for P. falciparum. Parasite invasion was then tested on the
cryopreserved reticulocytes derived from HSC maturation.
P. falciparum could invade cryopreserved reticulocytes subjected
to any of the 3 cryopreservation methods (parasite density: 4.2%
for glycerol solution, 4.1% for Glycerolyte and 8% for the
IMDM/10% DMSO/40% FCS; 3 independent assays). However,
the method using the Glycerolyte solution was discarded as clots
were observed during the thawing process. Therefore, for P. vivax
invasion, only reticulocytes cryopreserved with the Glycerol
solution and the Medium/10% DMSO/40% FCS solutions were
used. These were successfully invaded with the identification of
ring stages 24 h post invasion and the parasite density was counted
for all 8 independent experiments (Figure 5). P. falciparum and
P. vivax could invade the erythroblasts stages, with both fresh and
cryopreserved HSC derived cells (Figure 4c).
Parasite density obtained after invasion of cryopreserved HSC
derived reticulocytes varied substantially (from 0.19% to 2.43%)
according to the P. vivax isolate used. However, parasite density for
each single parasite isolate did not vary when using different
batches of cryopreserved reticulocytes. The range of parasite
densities after invasion was between 0.19% and 2.43% for
reticulocyte cryopreserved in the IMDM/10% DMSO/40%
FCS solution. In comparison, invasion rate of reticulocytes
cryopreserved in glycerol solution was 30 to 50% less efficient in
4 replicates) (Figure 5).
Discussion
This is the first report showing a reliable cryopreservation
protocol for HSC-derived reticulocytes derived that can be
successfully invaded by both cryopreserved P. falciparum and
P. vivax isolates. This will contribute to the establishment of
a continuous P. vivax culture, since the latter requires a continuous
supply of reticulocytes in a large amount. Until now, availability of
adequate quantities of reticulocytes was a bottleneck, as they
represent only 1% of all circulating cells in the blood stream [24].
Several approaches have been tested to tackle this problem. One
used blood from hematochromatosis patients [25] as they need to
be regularly bled and have a higher percentage of reticulocytes.
This method allowed for short-term P. vivax in vitro cultures for up
to 15 days. However, the limited access to hemochromatosis
patients is a drawback. A second source of reticulocytes is cord
blood, in which the reticulocyte concentration is slightly higher (3–
Figure 2. Evolution of reticulocytes (continuous line) and red blood cells (dotted line) counts from day 12 to day 20 of HSCs
maturation. Each value represents the median a total of 6 independent experiments, and vertical bars represent the interquartile range (IQR).
Reticulocytes were identified by cresyl blue staining.
doi:10.1371/journal.pone.0040798.g002
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8%) than in adult blood; this source has been previously used
permitted maintaining P. vivax fresh isolates in culture for about
one month [26]. However, the low amount of reticulocytes
obtained did not allow for an optimal parasite multiplication
(parasite density ,0.7%). Moreover, substantial variation of
parasite densities obtained makes this protocol unsuitable for
studying P. vivax biology.
Cord blood HSCs represent a valuable source, as reticulocytes
can be produced in substantial quantities [9,27]. The differenti-
ation protocol presented here was adapted from the one published
by Giarratana et al. [8,28], which originally matured HSCs into
Figure 3. Expression of reticulocyte surface markers by flow cytometry. 3a: Expression of HSCs surface markers at different maturation
stages characterized by flow cytometry. Cells were collected, respectively at 8 days, 11 days, 14 days and 17 days of maturation and stained with
specific antibodies against CD36, CD45, CD71 and CD325a receptors, respectively. Each value represents the median percentage for 3 independent
experiments (vertical bars represent the extreme values in this case). 3b: Comparison of the surface markers expression (%) at day 14 after thawing for
3 different cryopreservation protocols compared to fresh HSC derived reticulocytes (median % values of 3 independent experiments; vertical bars
represent the extreme values in this case).
doi:10.1371/journal.pone.0040798.g003
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erythroid lineage by using a co-culture with stromal cells. The
latter are mainly used to retain nucleated cells, free nuclei and
debris so that the culture appears cleaner. We have modified this
technique by omitting the co-culture with stromal cells, which
resulted in a less pure population of enucleated cells in our model
(20% enucleated/80% nucleated cells versus 100% enucleated cells
when using stromal cells) since the nucleated cells were not
retained by the MS5 layer. Nevertheless, while Giarratana aimed
at obtaining RBCs with a lifespan of about 120 days, achieved
during the later stages of RBC maturation, our purpose was to
obtain reticulocytes whose lifespan is 2 days. This explains why
maturation was stopped at the peak of the reticulocyte concen-
tration (D14). Moreover, reticulocytes obtained after maturation
on a MS5 layer gave similar result in term of invasion than those
produced without stromal cells (data not shown). A previous
attempt of producing HSC-derived reticulocytes without using
stromal cells in co-culture attained a maximum reticulocyte
concentration of 0.5% [9]. This is in contrast with the results of
our methods which produced a 40-fold (20%) higher concentra-
tion of reticulocytes. The low efficiency of the previous method
could be explained by several factors such as the use of non-
detoxified BSA (a key factor for the last steps of maturation and
enucleation) [27], a very high (lethal?) concentration of mono-
thioglycerol, or the absence of inositol or folic acid. It is also
important to mention that the parasite density in culture supported
by HSC-derived reticulocytes obtained with our method was
substantially higher (2.5% vs 0.0015%) than that reported for the
previous one [9], providing sufficient biological material to
possibly keep the culture for a longer period.
During the invasion assays we performed, the cell population
was not purely composed by reticulocytes but contained also
erythroblasts. Both P. falciparum and P. vivax were able to invade
these cells, as previously reported [29]. No information on the
quality of the parasite development in this type of cells is currently
available.
FACS analyses of both fresh and cryopreserved reticulocytes
showed the expression of CD235a marker (Glycophorin A), an
important receptor for P. falciparum invasion [30]. Its role in P. vivax
invasion has not been described yet but its homology with the
Duffy Binding Protein (DBP) [31,32] suggests a potential role in
the P. vivax invasion process of the reticulocytes. Thus the
Figure 4. Pictures of HSC-derived reticulocyte invaded by Plasmodium. 4a: Infected enucleated cells by P. falciparum 24 h after invasion. (A)
Fresh reticulocytes derived from HSCs maturation, (B) Cryopreserved reticulocytes with glycerolyte, (C) Cryopreserved reticulocytes with glycerol
solution, (D) Cryopreserved reticulocytes with Medium/40% FCS/10% DMSO (3 replicates). 4b: Infected reticulocytes by P. vivax 24 h after invasion. (A)
Fresh reticulocytes derived from HSCs maturation, (B) Cryopreserved reticulocytes with glycerol solution, (C) Cryopreserved reticulocytes with
Medium/40% FCS/10% DMSO (8 replicates). 4c: Infected erythroblast (A) By P. falciparum. (B) By P. vivax (8 replicates).
doi:10.1371/journal.pone.0040798.g004
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cryopreservation protocol kept the important receptors on the
reticulocyte membrane.
The added value of the work presented is the set up of
a cryopreservation technique for the long-term storage of cord
blood HSC-derived reticulocytes, providing a continuous source
for the performance of invasion assays and possibly the
maintenance of a P. vivax in vitro culture. The technique is robust
as it has been tested on several HSCs batches of that gave
comparable results with a single P. vivax isolates (Fig.5, PV3/CB 81
and 23). The reticulocyte cryopreservation using Glycerolyte was
abandoned due to the presence of clots during thawing. It is
unclear why this occurred but a possible hypothesis would be the
harmful effect of glycerolyte on nucleated cells.
The source of reticulocytes for a P. vivax invasion assay is not
limited to HSC-derived cells. Borlon et al [32] were able to
maintain a short-term (up to 10 days) P. vivax culture using
reticulocytes directly concentrated from cord blood. This was done
with similar efficacy with both fresh and frozen parasites and
reticulocytes (using Glycerolyte 57 as cryopreservant). The
advantage of concentrating reticulocytes from cord blood is that
these are almost immediately available (pending availability of
cord blood) while HSC-derived ones need 14 days to mature.
Nevertheless, with the former technique the concentration process
(percoll centrifugation, application of several washing/concentra-
tion steps) could damage the cells and affect the invasion efficiency
while using HSC-derived reticulocytes may guarantee a more
homogeneous and standardised cell population. Eventually, using
both methods: concentrated from cord blood and HSC-derived
reticulocytes could substantially increase the amount of available
reticulocytes from a single cord blood sample.
In conclusion, the cryopreservation method described in this
paper provides a continuous and substantial source of reticulo-
cytes, possibly a first step to achieve the continuous in vitro culture
of P. vivax. In addition, the possibility of cryopreserving both
reticulocytes and parasites offers the opportunity of investigating
P. vivax invasion assays/culture in non-endemic countries, opening
this field of research to more research groups thus increasing the
probability of fast advances in knowledge.
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